MCHP (NASDAQ: MCHP) insider plans Rule 144 sale of 4,400 shares

Rhea-AI Filing Summary

An affiliated holder of the issuer has filed a notice of proposed sale under Rule 144 to sell up to 4,400 shares of common stock. The filing lists an aggregate market value of $345,744.08 for the planned sale and indicates 541,135,458 common shares outstanding. The shares to be sold were acquired as restricted stock grants from the issuer on multiple dates between May 2023 and November 2024. The seller represents that they are not aware of any undisclosed material adverse information about the issuer’s operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4400	345744.08	541135458	02/12/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/15/2023	Restricted Stock	Issuer			596	05/15/2023	Not Applicable
Common	02/15/2024	Restricted Stock	Issuer			440	02/15/2024	Not Applicable
Common	08/15/2023	Restricted Stock	Issuer			286	08/15/2023	Not Applicable
Common	08/15/2023	Restricted Stock	Issuer			571	08/15/2023	Not Applicable
Common	11/15/2024	Restricted Stock	Issuer			488	11/15/2024	Not Applicable
Common	08/15/2024	Restricted Stock	Issuer			506	08/15/2024	Not Applicable
Common	05/15/2023	Restricted Stock	Issuer			286	05/15/2023	Not Applicable
Common	05/15/2024	Restricted Stock	Issuer			665	05/15/2024	Not Applicable
Common	11/15/2023	Restricted Stock	Issuer			562	11/15/2023	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for MCHP disclose?

The Form 144 discloses a proposed sale of 4,400 common shares under Rule 144 with an aggregate market value of $345,744.08. It outlines how the shares were acquired as restricted stock grants from May 2023 through November 2024.

How many MCHP shares are planned for sale under Rule 144?

The filing indicates a planned sale of 4,400 common shares under Rule 144. These shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services and are listed as trading on the NASDAQ exchange.

What is the aggregate market value of the MCHP shares in this Form 144?

The planned Rule 144 sale covers shares with an aggregate market value of $345,744.08. This figure is based on the 4,400 common shares identified in the filing and reflects the market value at the time of the notice.

How were the MCHP shares in the Form 144 originally acquired?

The shares were acquired as restricted stock directly from the issuer on several grant dates from May 15, 2023 through November 15, 2024. Each entry lists the grant date, number of shares acquired, and that cash payment details are not applicable.

Does the Form 144 mention prior MCHP share sales in the past 3 months?

The document includes a section for securities sold during the past three months, but no specific transactions are detailed in the provided excerpt. The primary focus is on the upcoming 4,400-share sale under Rule 144 described in the securities information table.

What representation does the seller make in the MCHP Form 144?

The seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed. This representation is part of the standard certification language included with the notice of proposed sale.